chr4-6294720-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006005.3(WFS1):​c.713-321G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0626 in 392,278 control chromosomes in the GnomAD database, including 1,045 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.056 ( 343 hom., cov: 33)
Exomes 𝑓: 0.067 ( 702 hom. )

Consequence

WFS1
NM_006005.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.874

Publications

7 publications found
Variant links:
Genes affected
WFS1 (HGNC:12762): (wolframin ER transmembrane glycoprotein) This gene encodes a transmembrane protein, which is located primarily in the endoplasmic reticulum and ubiquitously expressed with highest levels in brain, pancreas, heart, and insulinoma beta-cell lines. Mutations in this gene are associated with Wolfram syndrome, also called DIDMOAD (Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness), an autosomal recessive disorder. The disease affects the brain and central nervous system. Mutations in this gene can also cause autosomal dominant deafness 6 (DFNA6), also known as DFNA14 or DFNA38. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2009]
WFS1 Gene-Disease associations (from GenCC):
  • Wolfram-like syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics, ClinGen, Orphanet
  • Wolfram syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • autosomal dominant nonsyndromic hearing loss 6
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • cataract 41
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Wolfram syndrome 1
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset nuclear cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • type 2 diabetes mellitus
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 4-6294720-G-T is Benign according to our data. Variant chr4-6294720-G-T is described in ClinVar as Benign. ClinVar VariationId is 673197.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.167 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WFS1NM_006005.3 linkc.713-321G>T intron_variant Intron 6 of 7 ENST00000226760.5 NP_005996.2 O76024A0A0S2Z4V6
WFS1NM_001145853.1 linkc.713-321G>T intron_variant Intron 6 of 7 NP_001139325.1 O76024A0A0S2Z4V6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WFS1ENST00000226760.5 linkc.713-321G>T intron_variant Intron 6 of 7 1 NM_006005.3 ENSP00000226760.1 O76024

Frequencies

GnomAD3 genomes
AF:
0.0558
AC:
8486
AN:
152128
Hom.:
344
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0157
Gnomad AMI
AF:
0.0186
Gnomad AMR
AF:
0.0608
Gnomad ASJ
AF:
0.0308
Gnomad EAS
AF:
0.177
Gnomad SAS
AF:
0.0491
Gnomad FIN
AF:
0.0650
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0713
Gnomad OTH
AF:
0.0431
GnomAD4 exome
AF:
0.0670
AC:
16086
AN:
240032
Hom.:
702
AF XY:
0.0643
AC XY:
8277
AN XY:
128636
show subpopulations
African (AFR)
AF:
0.0154
AC:
107
AN:
6940
American (AMR)
AF:
0.0800
AC:
971
AN:
12134
Ashkenazi Jewish (ASJ)
AF:
0.0296
AC:
195
AN:
6578
East Asian (EAS)
AF:
0.170
AC:
2021
AN:
11894
South Asian (SAS)
AF:
0.0394
AC:
1629
AN:
41392
European-Finnish (FIN)
AF:
0.0698
AC:
776
AN:
11116
Middle Eastern (MID)
AF:
0.0179
AC:
16
AN:
894
European-Non Finnish (NFE)
AF:
0.0702
AC:
9577
AN:
136360
Other (OTH)
AF:
0.0624
AC:
794
AN:
12724
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
769
1538
2306
3075
3844
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
92
184
276
368
460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0557
AC:
8482
AN:
152246
Hom.:
343
Cov.:
33
AF XY:
0.0563
AC XY:
4188
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.0157
AC:
652
AN:
41558
American (AMR)
AF:
0.0608
AC:
931
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0308
AC:
107
AN:
3472
East Asian (EAS)
AF:
0.177
AC:
911
AN:
5156
South Asian (SAS)
AF:
0.0487
AC:
235
AN:
4824
European-Finnish (FIN)
AF:
0.0650
AC:
691
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0713
AC:
4847
AN:
67988
Other (OTH)
AF:
0.0426
AC:
90
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
406
812
1219
1625
2031
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
108
216
324
432
540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0643
Hom.:
302
Bravo
AF:
0.0557
Asia WGS
AF:
0.0890
AC:
311
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.37
DANN
Benign
0.54
PhyloP100
-0.87
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12511742; hg19: chr4-6296447; API